{"id":"nicardipine-esmolol","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Flushing"},{"rate":null,"effect":"Bradycardia"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Nicardipine blocks L-type calcium channels in vascular smooth muscle, causing vasodilation and reduced peripheral vascular resistance. Esmolol is a short-acting beta-1 selective blocker that decreases heart rate and cardiac contractility. Together, they provide complementary antihypertensive and cardioprotective effects, commonly used in acute care settings for rapid blood pressure control.","oneSentence":"This is a combination of nicardipine (a calcium channel blocker) and esmolol (a beta-1 selective adrenergic antagonist) that work synergistically to reduce blood pressure and heart rate through different pathways.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:57:14.229Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute hypertension management"},{"name":"Perioperative hypertension and tachycardia control"}]},"trialDetails":[{"nctId":"NCT05430724","phase":"NA","title":"The Effects of Nicardipine and Esmolol Applied for Controlled Hypotension","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2022-05-12","conditions":"Hypotension, Surgery-Complications, Oxygen Deficiency","enrollment":80},{"nctId":"NCT01422616","phase":"PHASE3","title":"Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)","status":"COMPLETED","sponsor":"The George Institute","startDate":"2012-03","conditions":"Ischemic Stroke, High Blood Pressure","enrollment":4587},{"nctId":"NCT02116868","phase":"NA","title":"Pupillary Reflex Measurement to Guide Intraoperative Analgesia During Laparoscopic Surgery","status":"COMPLETED","sponsor":"Central Hospital, Nancy, France","startDate":"2014-03","conditions":"Scheduled Laparoscopic Surgery","enrollment":100},{"nctId":"NCT01232400","phase":"NA","title":"Study to Evaluate Esmolol (Brevibloc) to Manage Cardiac Function in Patients With Subarachnoid Hemorrhage","status":"WITHDRAWN","sponsor":"University of Michigan","startDate":"2014-07","conditions":"Subarachnoid Hemorrhage","enrollment":""},{"nctId":"NCT01951950","phase":"PHASE1","title":"Nicardipine vs Esmolol Craniotomy Emergence","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2013-09","conditions":"Brain Tumors","enrollment":40},{"nctId":"NCT00716079","phase":"NA","title":"The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial","status":"COMPLETED","sponsor":"The George Institute","startDate":"2008-09","conditions":"Intracerebral Hemorrhage, Stroke, Hypertension","enrollment":2839},{"nctId":"NCT01171911","phase":"PHASE4","title":"Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery","status":"UNKNOWN","sponsor":"Nanjing Medical University","startDate":"2010-10","conditions":"Acute Coronary Syndrome, Coronary Artery Disease","enrollment":200},{"nctId":"NCT00226096","phase":"NA","title":"Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage","status":"COMPLETED","sponsor":"The George Institute","startDate":"2005-11","conditions":"CVA (Cerebrovascular Accident), Cerebral Hemorrhage, Intracranial Hemorrhages","enrollment":404}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Calcium channel blocker"],"phase":"marketed","status":"active","brandName":"Nicardipine , Esmolol","genericName":"Nicardipine , Esmolol","companyName":"Nanjing Medical University","companyId":"nanjing-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a combination of a calcium channel blocker (nicardipine) and a beta-1 selective adrenergic antagonist (esmolol) that work synergistically to reduce blood pressure and heart rate through different pathways. Used for Acute hypertension management, Perioperative hypertension and tachycardia control.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}